Skip to main content
Tech.euFundingExplorerBeta

Solence

Solence was founded by Clara Stephenson in 2022 with the mission to make personalised and patient-centric care available to all women with PCOS, the most prevalent hormonal condition among women.

Solence has raised €1.6M across 1 funding round from 6 investors, most recently a Seed round in Jul 2025. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.6M
€1,600,000
Funding rounds
1
Investors
6
distinct backers
Active since
2025-07
latest 2025-07

Funding by year

EUR raised per year
Solence — funding by year — interactive chart.
Data table
Solence — funding by year
2025€1.6M

Signals

High confidence
Raise-next likelihood61
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-07-10Seed€1.6MAngel Investors,Berthe Latreille,Bpifrance,Céline Lazorthes,Impact Shakers Ventures,Stéphane MardelView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData